Dayton Misfeldt, Director at SUNESIS PHARMACEUTICALS INC (SNSS), bought 1,750,000 shares at $0.84 ($1.5M) on 2015-12-21, disclosed to the SEC on 2015-12-21.
Open-market purchase of $1.5M SNSS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.84 | 32,725 | $27K | 1.9% |
| 2 | $0.84 | 1,717,275 | $1.4M | 98.1% |
| Total | $0.84 avg | 1,750,000 | $1.5M | 100% |
| Filing → |
| SNSS | SELL | 2014-08-29 | $2.4M | — | Filing → |
| SNSS | SELL | 2014-08-12 | $4.9M | — | Filing → |
| SNSS | BUY | 2010-07-01 | $6.7M | — | Filing → |